In contrast, the long-term upregulation of catecholamines, often present in patients with heart failure, antagonizes the actions of insulin, promotes lipolysis, and increases circulating FFA levels, all of which can lead to insulin resistance [9]. This evidence concerns the gene INS and Insulin resistance.